Vaccine News and Research

Latest Vaccine News and Research

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

A new case study on the report of multisystem inflammatory syndrome (MISC) in a 22-year-old woman in South Korea after vaccination.

5 Dec 2021

The emergence and evolution of SARS-CoV-2 and its VOCs

A review article discusses the evolution of SARS-CoV-2 and the emergence of variants of concern.

5 Dec 2021

New test can quickly and easily assess antibody effectiveness against COVID-19 variants

Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person's neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.

4 Dec 2021

'Combination' adjuvant may boost the protective power of vaccines

Scientists at La Jolla Institute for Immunology and Massachusetts Institute of Technology, have found a possible way to improve the effectiveness of COVID-19 vaccines - and any vaccine.

4 Dec 2021

Is it time to change the definition of ‘fully vaccinated’?

As more indoor venues require proof of vaccination for entrance and with winter — as well as omicron, a new covid variant — looming, scientists and public health officials are debating when it will be time to change the definition of "fully vaccinated" to include a booster shot.

3 Dec 2021

Minister for Equalities calls for everyone to get COVID-19 jabs

The final report into Covid-19 disparities sets out how Government research identified the key virus risk factors - such as occupation, household size and wider living circumstances - for specific groups and used that data to provide targeted, evidence-based guidance and advice on how to reduce the risk of infection.

3 Dec 2021

New nanoparticle adjuvant could help make vaccines more powerful

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant - a compound that stimulates the immune system to produce a stronger response.

3 Dec 2021

Evaluating comparative effectiveness of Pfizer-BioNtech and Moderna vaccines among US veterans

A new study provided evidence of a lower 24-week risk of COVID-19–related outcomes among recipients of the mRNA-1273 vaccine, compared to their counterparts who received the BNT162b2 vaccine.

3 Dec 2021

Effectiveness of COVID-19 vaccines in New York State

A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.

3 Dec 2021

Predicting COVID-19 transmission dynamics in the USA

Researchers used an SEIR type compartmental model to predict the dynamics of COVID-19 transmission in the USA.

3 Dec 2021

Characterization of two novel SARS-CoV-2 delta variant sublineages

Researchers characterized the two novel AY.43 sublineages of the SARS-CoV-2 delta variant with probable Brazilian origin.

3 Dec 2021

Risk of COVID-19 hospitalization among children with markers of uncontrolled asthma

The paper describes a national cohort study including all children in Scotland between the ages of 5 and 17 years who were part of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II).

3 Dec 2021

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

A recent study reports neutralizing efficacy for a fused peptide-antibody molecule against SARS-CoV-2, providing hope that therapeutic neutralizing antibodies may soon be available.

3 Dec 2021

Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

The current study used VHA electronic health records (EHR) to estimate the effectiveness of the booster dose in the USA against post-vaccination COVID-19.

3 Dec 2021

Modeling emergence and dynamics of new COVID-19 variants in the UK

Computer simulations describe global features observed in the daily number of cases and can be applied to any country of interest.

3 Dec 2021

Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

...

2 Dec 2021

Link between tobacco product use and alcohol consumption with anti-SARS-CoV-2 antibody titers after BNT162b2 vaccine

In a Japanese study, smoking, HNB tobacco products, and alcohol use have been shown to impair the immunological response to the COVID-19 vaccination.

2 Dec 2021

£700 million will help hospitals across England tackle waiting lists and improve care

Hospitals across the country will benefit from a share of £700 million to expand wards, install modular operating theaters, upgrade outpatient spaces and MRI and screening technology, to help reduce waiting lists.

2 Dec 2021

Government signs new contracts to secure the supply of vaccine stock in light of new variant

The government has signed new contracts to secure the supply of our vaccine stock to future proof the country's vaccine programme.

2 Dec 2021

Most U.S. states failed to prioritize cancer patients for COVID-19 vaccine rollout

Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations, despite recommendations from the Centers for Disease Control and Prevention, according to a study being presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2021

Vaccine News and Research

Latest Vaccine News and Research

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

The emergence and evolution of SARS-CoV-2 and its VOCs

New test can quickly and easily assess antibody effectiveness against COVID-19 variants

'Combination' adjuvant may boost the protective power of vaccines

Is it time to change the definition of ‘fully vaccinated’?

Minister for Equalities calls for everyone to get COVID-19 jabs

New nanoparticle adjuvant could help make vaccines more powerful

Evaluating comparative effectiveness of Pfizer-BioNtech and Moderna vaccines among US veterans

Effectiveness of COVID-19 vaccines in New York State

Predicting COVID-19 transmission dynamics in the USA

Characterization of two novel SARS-CoV-2 delta variant sublineages

Risk of COVID-19 hospitalization among children with markers of uncontrolled asthma

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

Modeling emergence and dynamics of new COVID-19 variants in the UK

Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

Link between tobacco product use and alcohol consumption with anti-SARS-CoV-2 antibody titers after BNT162b2 vaccine

£700 million will help hospitals across England tackle waiting lists and improve care

Government signs new contracts to secure the supply of vaccine stock in light of new variant

Most U.S. states failed to prioritize cancer patients for COVID-19 vaccine rollout

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in